The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)
Clinical trial NCT04405739 · COMPLETED
Trial details
- NCT number
- NCT04405739
- Sponsor
- Ridgeback Biotherapeutics, LP
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2022-02-21
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.